Nordic Nanovector completes patient enrolment into Phase 1 trial of Betalutin® in Diffuse Large B Cell Lymphoma ...Middle East

OSLO, Norway, Dec. 1, 2020 /PRNewswire/ -- Nordic Nanovector ASA (OSE: NANO) announces that it has completed enrolment into the LYMRIT 37-05 Phase 1 clinical trial of Betalutin® (177Lu lilotomab satetraxetan) in patients with relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL)...

Hence then, the article about nordic nanovector completes patient enrolment into phase 1 trial of betalutin in diffuse large b cell lymphoma was published today ( Tuesday 01/12/2020 - 10:01 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Nordic Nanovector completes patient enrolment into Phase 1 trial of Betalutin® in Diffuse Large B Cell Lymphoma )

Also on site :

• Russia exposed plot to blow up Black Sea gas pipelines – Putin
• Police: Two killed in shooting at West San Jose shopping center
• OpenAI COO says ‘we have not yet really seen AI penetrate enterprise business processes’